Novoron
San Diego, US · Founded 2014 · Delaware corporation · 17 employees on LinkedIn · 2 known investors
Novoron develops lipoprotein-receptor small molecule therapies aimed at repairing damage and degeneration of the brain and spinal cord, including treatments for proteinopathies and neuroregeneration following traumatic injury. The company focuses on drug discovery for neurological conditions such as neurodegeneration and cognitive decline.
Founders & leadership
Novoron was founded in 2014 by Travis Stiles and Shawn Gahr.
TS
Travis StilesinCo-founder · President and CEO
SG
Shawn GahrinCo-founder, COO & CFO
DW
David WeinerExecutive Chairman
RM
Ryan McMillianCFO & Financial Strategy
Board
MG
Investors · 2
Reported raises · per SEC filings
Form D private placements$15.2M disclosed across 2 rounds · 2021–2022
▶$12.1MraisedDec 2022 · 2 investors · BiotechnologyRule 506(b)
▶$12.1MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Travis StilesExecutive Officer, Director
- Michael GoguenDirector
- Shawn GahrExecutive Officer, Director
- Offering amount
- $12.1M
- Amount sold
- $12.1M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedJul 2021 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedJul 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Travis StilesExecutive Officer, Director
- Shawn GahrDirector
- Michael GoguenDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapRegeneron NASDAQ: REGN www.regeneron.com21 shared keywordsRegeneron is a biotechnology company that develops medicines ranging from biologics to genetic medicines to treat serious diseases across areas such as metabolic disease, ophthalmology, and rare disease. The company focuses on research and development driven by human biology, with a clinical trial pipeline addressing conditions like generalized myasthenia gravis.
Longeveron14 shared keywordsLongeveron is a clinical-stage biotechnology company developing allogeneic cellular therapies for life-threatening conditions affecting children and the elderly. Its investigational candidate is being evaluated for indications including Hypoplastic Left Heart Syndrome, Pediatric Dilated Cardiomyopathy, Alzheimer's Disease, and age-related frailty.
Pharmaron13 shared keywordsPharmaron is a life science contract research and manufacturing service provider covering drug discovery, preclinical and clinical development, and commercialization. It serves pharmaceutical and biotech partners across small molecules, biologics, and cell and gene therapy (CGT) products.
InGeneron10 shared keywordsInGeneron develops regenerative cell therapies that use a patient's adult stem cells and other regenerative cells harvested from fat or bone marrow to treat specific injuries. The company focuses on developing FDA-approved therapies through clinical trials and research in the regenerative medicine field.
Imunon10 shared keywordsImunon develops nucleic acid-based (DNA) immunotherapies and vaccines, including anti-cancer therapies and vaccines for infectious diseases and cancer. The company builds proprietary immunology and DNA-based platforms aimed at difficult-to-treat conditions.
Companies competing with Novoron for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Novoron do?
- Novoron develops lipoprotein-receptor small molecule therapies aimed at repairing damage and degeneration of the brain and spinal cord, including treatments for proteinopathies and neuroregeneration following traumatic injury. The company focuses on drug discovery for neurological conditions such as neurodegeneration and cognitive decline.
- Who founded Novoron?
- Novoron was founded by Travis Stiles, Shawn Gahr in 2014.
- Who are Novoron's investors?
- Novoron's investors include Two Bear Capital, Backstage Capital.
- How much funding has Novoron raised?
- Novoron has disclosed $15.2M raised across 2 rounds.
- Where is Novoron headquartered?
- Novoron is headquartered in San Diego, US.